Chronic Myeloid Leukemia
Watch this new video to learn about the role of PCR (polymerase chain reaction) testing and ongoing monitoring for CML:Video supported by a grant from Novartis Oncology.
The information in this section can help you talk with members of your healthcare team and take an active role in your treatment. Knowing what to expect and being able to make informed decisions about your cancer treatment are important aspects of coping with your disease. You can skim sections to find what you want to read now - and continue reading whenever you're ready for more information.
What You Should Know
- CML is one of four main types of leukemia.
- Hematologists and oncologists are specialists who treat people who have CML or other types of blood cancer.
- Most CML patients are treated with daily oral drug therapy.
- Since 2001, the Food and Drug Administration approved six new drugs
- There is a growing number of people living with CML.
What You Should Do
- Talk with your doctor about your diagnostic tests and what the results mean.
- Make sure your doctor continually monitors your response to medication, which is essential to bringing your CML under control.
What Is CML?
Chronic myeloid leukemia (CML) is a cancer of the bone marrow and blood. CML is usually diagnosed in its chronic phase when treatment is very effective for most patients. CML has three phases.
CML is also called:
- chronic myelogenous leukemia
- chronic granulocytic leukemia
- chronic myelocytic leukemia.
Source: Chronic Myeloid Leukemia. Reviewed by Neil P. Shah, MD, PhD and Robert J. Arceci, MD, PhD.